These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses? Fromm D Clin Invest Med; 1987 May; 10(3):251-8. PubMed ID: 3304754 [TBL] [Abstract][Full Text] [Related]
6. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandins in the gut and their relationship to non-steroidal anti-inflammatory drugs. Semble EL; Wu WC Baillieres Clin Rheumatol; 1989 Aug; 3(2):247-69. PubMed ID: 2670254 [TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease. Rainsford KD; Stetsko PI; Sirko SP; Debski S J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of gastric and duodenal damage and protection. Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394 [TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment. Hawkey CJ Scand J Gastroenterol Suppl; 1996; 220():124-7. PubMed ID: 8898449 [TBL] [Abstract][Full Text] [Related]
11. Some of the factors that may mediate or modify the gastrointestinal mucosal damage induced by non-steroidal anti-inflammatory drugs. Gyires K Agents Actions; 1994 Mar; 41(1-2):73-9. PubMed ID: 8079824 [TBL] [Abstract][Full Text] [Related]
12. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation. Kirchner T; Aparicio B; Argentieri DC; Lau CY; Ritchie DM Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):417-23. PubMed ID: 9223651 [TBL] [Abstract][Full Text] [Related]
13. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Bertolini A; Ottani A; Sandrini M Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Actions of therapeutic agents. Ivey KJ Am J Med; 1988 Feb; 84(2A):41-8. PubMed ID: 2894763 [TBL] [Abstract][Full Text] [Related]
15. Role of prostaglandins in gastroduodenal mucosal protection. Wilson DE J Clin Gastroenterol; 1991; 13 Suppl 1():S65-71. PubMed ID: 1940199 [TBL] [Abstract][Full Text] [Related]
17. Some new aspects of gastric mucosal protection and damage. Bennett A Acta Physiol Hung; 1989; 73(2-3):179-83. PubMed ID: 2688358 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of non-steroidal anti-inflammatory drug gastropathy. Fiorucci S; Antonelli E; Morelli O; Morelli A Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S6-13. PubMed ID: 10379463 [TBL] [Abstract][Full Text] [Related]
19. Disturbances in the balance between aggressive and protective factors in the gastric and duodenal mucosa. Aase S Scand J Gastroenterol Suppl; 1989; 163():17-23. PubMed ID: 2683025 [TBL] [Abstract][Full Text] [Related]
20. Ulcerogenic drugs and antiulcer compounds: effects on gastroduodenal mucosa. Johansson C Scand J Gastroenterol Suppl; 1987; 128():24-32. PubMed ID: 3477002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]